TY  - GEN
AU  - Efebera,Yvonne A
AU  - Geyer,Susan
AU  - Andritsos,Leslie
AU  - Vasu,Sumithira
AU  - Jaglowski,Samantha
AU  - Bingman,Anissa
AU  - Blum,William
AU  - Klisovic,Rebecca
AU  - Hofmeister,Craig C
AU  - Benson,Don M
AU  - Penza,Sam
AU  - Elder,Patrick
AU  - Cortright,Katie
AU  - Kitzler,Rhonda
AU  - Coombes,Kevin
AU  - O'Donnell,Lynn
AU  - Daneault,Beth
AU  - Bradbury,Hillary
AU  - Zhang,Jianying
AU  - Chen,Xilin
AU  - Garman,Sabrina
AU  - Ranganathan,Parvathi
AU  - Yu,Xueyan
AU  - Hofstetter,Jessica
AU  - Yu,Jianhua
AU  - Garzon,Ramiro
AU  - Scrape,Scott R
AU  - Lozanski,Gerard
AU  - Devine,Steven M
TI  - Atorvastatin for the Prophylaxis of Acute Graft-versus-Host Disease in Patients Undergoing HLA-Matched Related Donor Allogeneic Hematopoietic Stem Cell Transplantation (allo-HCT)
SN  - 1523-6536
PY  - 2016///0929
KW  - Acute Disease
KW  - Adult
KW  - Aged
KW  - Allografts
KW  - Atorvastatin
KW  - administration & dosage
KW  - Disease-Free Survival
KW  - Female
KW  - Graft vs Host Disease
KW  - etiology
KW  - Hematopoietic Stem Cell Transplantation
KW  - Histocompatibility Testing
KW  - Humans
KW  - Male
KW  - Middle Aged
KW  - Survival Rate
KW  - Tissue Donors
N1  - Publication Type: Clinical Trial, Phase II; Journal Article; Research Support, N.I.H., Extramural
UR  - https://doi.org/10.1016/j.bbmt.2015.07.034
ER  -